OTCMKTS:SARTF - Sartorius Aktiengesellschaft Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
+0.30 (1.20%)

This chart shows the closing price for SARTF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Sartorius Aktiengesellschaft Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SARTF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SARTF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for Sartorius Aktiengesellschaft in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $474.00.

This chart shows the closing price for SARTF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 6 polled investment analysts is to buy stock in Sartorius Aktiengesellschaft. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/26/2021DZ BankReiterated RatingNeutral
5/25/2021Societe GeneraleUpgradeHold ➝ Buy
3/18/2021DZ BankReiterated RatingNeutral
2/10/2021DZ BankReiterated RatingSell
2/1/2021Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
11/10/2020KeyCorpInitiated CoverageSector Weight
10/22/2020DZ BankReiterated RatingSell
10/20/2020JPMorgan Chase & Co.Reiterated RatingBuy
9/28/2020Berenberg BankReiterated RatingHold
9/25/2020JPMorgan Chase & Co.Reiterated RatingBuy
7/24/2020DZ BankReiterated RatingSell
7/21/2020JPMorgan Chase & Co.Reiterated RatingBuy
6/8/2020UBS GroupDowngradeNeutral ➝ Sell
4/24/2020DZ BankReiterated RatingSell
2/5/2020DZ BankReiterated RatingSell
11/22/2019DZ BankReiterated RatingSell
10/22/2019DZ BankReiterated RatingSell
7/19/2019DZ BankReiterated RatingSell
5/15/2019DZ BankReiterated RatingSell
4/2/2019DZ BankReiterated RatingSell
6/19/2018DZ BankReiterated RatingSell
5/3/2018DZ BankReiterated RatingSell
2/5/2018DZ BankReiterated RatingSell
7/21/2017DZ BankReiterated RatingSell
6/2/2017DZ BankReiterated RatingSell
3/22/2017DZ BankReiterated RatingNeutral
2/1/2017DZ BankReiterated RatingBuy
(Data available from 6/23/2016 forward)
Sartorius Aktiengesellschaft logo
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Read More

Today's Range

Now: $474.00
Low: $474.00
High: $474.00

50 Day Range

MA: $454.66
Low: $359.05
High: $548.90

52 Week Range

Now: $474.00
Low: $268.00
High: $550.00



Average Volume

100 shs

Market Capitalization

$16.23 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Sartorius Aktiengesellschaft?

The following Wall Street analysts have issued stock ratings on Sartorius Aktiengesellschaft in the last year: Berenberg Bank, Deutsche Bank Aktiengesellschaft, DZ Bank AG, JPMorgan Chase & Co., KeyCorp, Societe Generale, and Zacks Investment Research.
View the latest analyst ratings for SARTF.

What is the current price target for Sartorius Aktiengesellschaft?

0 Wall Street analysts have set twelve-month price targets for Sartorius Aktiengesellschaft in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Sartorius Aktiengesellschaft in the next year.
View the latest price targets for SARTF.

What is the current consensus analyst rating for Sartorius Aktiengesellschaft?

Sartorius Aktiengesellschaft currently has 3 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SARTF will outperform the market and that investors should add to their positions of Sartorius Aktiengesellschaft.
View the latest ratings for SARTF.

What other companies compete with Sartorius Aktiengesellschaft?

Other companies that are similar to Sartorius Aktiengesellschaft include Straumann, DENTSPLY SIRONA, Envista, SmileDirectClub, BIOLASE, American Medical Technologies, Lancer Orthodontics and Remedent.

How do I contact Sartorius Aktiengesellschaft's investor relations team?

Sartorius Aktiengesellschaft's physical mailing address is OTTO-BRENNER-STRASSE 20, GOETTINGEN 2M, 37079. The company's listed phone number is 49-55-130-80 and its investor relations email address is [email protected] The official website for Sartorius Aktiengesellschaft is www.sartorius.com.